A Centers for Disease Control and Prevention (CDC) advisory panel on Tuesday advised the agency to recommend all children between 5 and 11 get Pfizer’s COVID-19 vaccine. Panel members said they were worried about post-vaccination incidence of heart inflammation seen in youth, especially males, but ultimately agreed with CDC scientists that the benefits of vaccinating children, even those who have had COVID-19, would outweigh the risks. “I think the data supports that we have one more vaccine that saves lives in children and that we should be very confident to employ it to the maximum to do what it is meant to do without significant concerns about serious adverse events,” said Dr. Sarah Long, a panel member and professor of pediatrics at the Drexel University College of Medicine. The Food and Drug Administration (FDA) last week granted emergency use authorization to Pfizer’s jab for children 5–11 after its advisory panel, …